@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix ns1: <http://localhost:8555/solr/triplesselect?q=TRIPLE_UID:> .
@prefix ns2: <http://localhost:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:9wycjlj5&rows=> .
@prefix ns3: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RAF23LZ5Ia2xrMwIaYAcNBjBYEB7DcMGhRQ6S-u8tgOOA#> .
@prefix this: <http://purl.org/np/RAF23LZ5Ia2xrMwIaYAcNBjBYEB7DcMGhRQ6S-u8tgOOA> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
   <https://uts.nlm.nih.gov/uts/umls/concept/C5238873> ns3:approve <https://uts.nlm.nih.gov/uts/umls/concept/C2700456> .
}
sub:provenance {
   sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" , "S&T TWOC version 3" .
  sub:_version prov:value 2 .
  sub:assertion prov:generatedAtTime "2023-07-20T09:47:10.503521"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0003-4692-1377 ;
    prov:wasDerivedFrom <http://medrxiv.org/cgi/content/short/2021.02.04.21249959v1?rss=1> .
  rdf:OBJECT rdfs:label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" .
  rdf:OBJECT-POSITION rdfs:label "(0, 8)" .
  rdf:PREDICATE rdfs:label "approved" .
  rdf:PREDICATE-POSITION rdfs:label "112" .
  rdf:SUBJECT rdfs:label "Steroids ( Methylprednisolone or Dexamethasone ) and Tocilizumab ( TCZ ) , an interleukin-6 receptor antagonist" .
  rdf:SUBJECT-POSITION rdfs:label "(0, 8)" .
  rdf:Statement rdfs:label "Steroids (Methylprednisolone or Dexamethasone) and Tocilizumab (TCZ), an interleukin-6 receptor antagonist, are approved for the treatment of Cytokine release syndrome (CRS) or cytokine storm in India." .
  rdfs:ABSTRACT-UID ns2:50 "9wycjlj5" .
  rdfs:TRIPLE-UID ns1:9wycjlj5-TRIPLE-ABSTRACT-1 "9wycjlj5-TRIPLE-ABSTRACT-1" .
  <https://uts.nlm.nih.gov/uts/umls/concept/C2700456> rdfs:label "india" .
  <https://uts.nlm.nih.gov/uts/umls/concept/C5238873> rdfs:label "steroids" .
}
sub:pubinfo {
   sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "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" ;
    npx:hasSignature "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" ;
    npx:hasSignatureTarget this: .
  this: prov:wasAttributedTo orcid:0000-0003-4692-1377 .
}